Fesarius Therapeutics Raises $20 Million Series A To Advance Dermal Repair Technology
By Amit Chowdhry ● Jun 10, 2026
Fesarius Therapeutics announced the closing of an oversubscribed $20 million Series A financing round led by Jefferson Life Sciences, with participation from Johnson & Johnson Innovation – JJDC, Empire State Development’s NY Ventures, and the American Society of Plastic Surgeons (ASPS). The funding will support the expansion of the company’s commercial infrastructure, broaden national market coverage, pursue Breakthrough Device Designation and enhanced reimbursement pathways, and advance clinical studies for its OneStep procedure.